Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal failure in sickle cell anemia

W Y Wong1, D Elliott-Mills, D Powars

  • 1Department of Pediatrics, University of Southern California School of Medicine, Los Angeles, USA.

Hematology/Oncology Clinics of North America
|December 1, 1996
PubMed
Summary

End-stage renal disease (ESRD) is a significant complication for young adults with sickle cell anemia (SCA). Early detection and intervention are crucial for managing renal damage and improving outcomes for SCA patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Fractionally Charged Particles in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2025
Same author

Observation of the <math> </math> decay.

The European physical journal. C, Particles and fields·2024
Same author

Observation of Enhanced Long-Range Elliptic Anisotropies Inside High-Multiplicity Jets in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Observation of the ϒ(3S) Meson and Suppression of ϒ States in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Search for Narrow Trijet Resonances in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.

Physical review letters·2024

Area of Science:

  • Nephrology
  • Hematology
  • Genetics

Background:

  • Sickle cell anemia (SCA) frequently leads to end-stage renal disease (ESRD) in young adults.
  • The incidence of renal insufficiency in SCA patients is expected to rise as lifespans increase.
  • Understanding the mechanisms of renal damage in SCA is vital for effective treatment.

Purpose of the Study:

  • To highlight the importance of early recognition and intervention for renal complications in sickle cell anemia.
  • To discuss current and future therapeutic strategies for managing sickle cell nephropathy.
  • To explore the role of genetic factors and bone marrow transplantation in SCA management.

Main Methods:

  • Review of current understanding of sickle cell nephropathy pathophysiology.
  • Analysis of diagnostic clues for early detection of renal damage.
  • Evaluation of bone marrow transplantation (BMT) as a curative option and its associated risks.
  • Discussion of potential future therapies like gene therapy.

Main Results:

  • ESRD is a major complication in young adults with SCA, with increasing incidence.
  • Early diagnostic recognition and age-specific interventions are necessary to prevent irreversible renal damage.
  • Bone marrow transplantation (BMT) is the only current cure for SCA but carries risks like renal and pulmonary toxicity.
  • Genetic factors (beta s gene haplotypes) may help identify high-risk individuals for BMT.

Conclusions:

  • Tailoring management based on pathophysiology and therapeutic effects is essential for preserving renal function in SCA.
  • Identifying high-risk children for BMT based on genetic markers is a potential strategy.
  • Gene therapy without toxic preparative regimens represents the ultimate goal for SCA treatment.
  • Developing effective early therapeutic interventions during childhood and young adulthood is a key challenge.

Related Experiment Videos